{"database": "lobbying", "table": "lobbying_activities", "rows": [[1560286, "70215a43-5d6e-4e3a-ad2c-8f6af03d9485", "Q2", "BROWN RUDNICK LLP", 287895, "HOSPIRA, INC.", 2014, "second_quarter", "PHA", "Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products)", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", 50000, null, 0, 0, "2014-07-18T12:54:42.920000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1560286"], "units": {}, "query_ms": 1.8101049936376512, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}